"But Oakley said the findings are a step in the right direction. ???While our research is a long way from clinical trials, the fact that the bacteria-killing effects of the anti-inflammatories is different from conventional drugs means that they could be developed into new kinds of antibiotics,??? he said in the news release." . . . .